Alisha Angdembe is a Senior Health Economist who leverages data and analytics to inform high-impact decisions across the healthcare sector. With deep expertise in health economics and a clear understanding of the orphan drug landscape, she brings a unique, evidence-driven perspective. At the World Orphan Drug Congress 2025, Alisha will share practical insights on conceptualising economic models for rare conditions, highlighting approaches that improve rigour, relevance, and real-world applicability.